Skip to main content
. 2022 Jan 26;15(2):151. doi: 10.3390/ph15020151

Table 2.

Pros and cons of statin use for patients with malignant tumors.

Pros Cons
Economically reasonable and well-tolerated Off-label use
Except for hypocholesterolemia Hypercholesterolemia
Favorable for malignancies? Carcinogenic?
Many observational studies Biases
Statins improve cardiovascular outcomes Lipid-lowering drugs may not necessarily improve all causes of death